Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)

Ping Yen Liu, Cheng Huang Su, Feng Yu Kuo, Wen Lieng Lee, Yi Chih Wang, Wei Shiang Lin, Pao Hsien Chu, Tse Min Lu, Ping Han Lo, Cheng Han Lee, Wei Ren Lan, Chien Lung Huang, Shuji Tsukiyama, Wei Chen Yang, Li Chung Cheng, Virginia Rafael, Christian Nikolajsen, Wei Hsian Yin

研究成果: Comment/debate同行評審

摘要

A correction to this paper has been published: https://doi.org/10.1007/s12928-021-00779-2

原文English
頁(從 - 到)279-280
頁數2
期刊Cardiovascular Intervention and Therapeutics
37
發行號2
DOIs
出版狀態Published - 2022 4月

All Science Journal Classification (ASJC) codes

  • 放射學、核子醫學和影像學
  • 心臟病學與心血管醫學

指紋

深入研究「Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2022), 37, 2, (269-278), 10.1007/s12928-021-00771-w)」主題。共同形成了獨特的指紋。

引用此